Dr. Eli Shalom
Chief Executive Officer
A renowned researcher and expert in radiopharmaceuticals, recognized as a leading professional in the development and clinical applications of radioisotopes and radiotracers (SPECT & PET).
Prior to founding ISOTOPIA he held a key role in the research and development of SPECT and PET isotopes in the Soreq Nuclear Research Center.
His intense scientific and clinical research, combined with a unique perspective and a deep understanding of current and future market needs, have yielded numerous publications in reputed journals and a registered patent in the field of radioisotopes.
In his sparse spare time Eli enjoys mountain biking and practices yoga ashtanga.
Eli holds a PhD from the Hebrew University of Jerusalem and an Executive MBA from the Kellogg-Recanati International Program of Tel Aviv University.